Bristol Myers Squibb and Pfizer to make Eliquis (apixaban) available via Mark Cuban Cost Plus 91Ƶ Co.
Expands options for cash-paying patients to access the nation’s No. 1 prescribed oral blood thinner
Expands options for cash-paying patients to access the nation’s No. 1 prescribed oral blood thinner
New biosimilar added to portfolio reinforces the company's commitment to transparency and access.